Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure.

Authors

null

Deepika Reddy

Imperial College London, London, United Kingdom

Deepika Reddy , Taimur T. Shah , Marieke van Son , Stephanie Guillaumier , Feargus Hosking-Jervis , Stuart McCracken , Raj Nigam , Richard Hindley , Neil McCartan , Naveed Afzal , Henry Lewi , Raj Persad , Jaspal Virdi , Clement Orczyk , Caroline Moore , Manit Arya , Mark Emberton , Mathias Winkler , Hashim Uddin Ahmed , Tim Dudderidge

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5582)

DOI

10.1200/JCO.2020.38.15_suppl.5582

Abstract #

5582

Poster Bd #

163

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Comparative efficacy of local versus systemic salvage therapies for recurrent prostate cancer after primary radiotherapy.

Comparative efficacy of local versus systemic salvage therapies for recurrent prostate cancer after primary radiotherapy.

First Author: Glenn Bauman

Poster

2024 ASCO Genitourinary Cancers Symposium

Impact of <sup>18</sup>F-flotufolastat PET on management of patients with recurrent prostate cancer: Data from the SPOTLIGHT study.

Impact of 18F-flotufolastat PET on management of patients with recurrent prostate cancer: Data from the SPOTLIGHT study.

First Author: Przemyslaw Twardowski

Poster

2023 ASCO Genitourinary Cancers Symposium

Multicenter population-level analysis of systemic therapy use in metastatic or recurrent prostate cancer.

Multicenter population-level analysis of systemic therapy use in metastatic or recurrent prostate cancer.

First Author: Heba Mohamed